ATE448322T1 - Erhöhte in vitro-synthese von aktiven, disulfidbrücken-enthaltenden proteinen - Google Patents

Erhöhte in vitro-synthese von aktiven, disulfidbrücken-enthaltenden proteinen

Info

Publication number
ATE448322T1
ATE448322T1 AT01968701T AT01968701T ATE448322T1 AT E448322 T1 ATE448322 T1 AT E448322T1 AT 01968701 T AT01968701 T AT 01968701T AT 01968701 T AT01968701 T AT 01968701T AT E448322 T1 ATE448322 T1 AT E448322T1
Authority
AT
Austria
Prior art keywords
increased
vitro synthesis
disulfide bridge
containing proteins
bridge containing
Prior art date
Application number
AT01968701T
Other languages
English (en)
Inventor
James Swartz
Dong-Myung Kim
Original Assignee
Univ Leland Stanford Junior
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Leland Stanford Junior filed Critical Univ Leland Stanford Junior
Application granted granted Critical
Publication of ATE448322T1 publication Critical patent/ATE448322T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/107—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
    • C07K1/113—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides without change of the primary structure
    • C07K1/1133—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides without change of the primary structure by redox-reactions involving cystein/cystin side chains

Landscapes

  • Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Analytical Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Peptides Or Proteins (AREA)
AT01968701T 2000-09-06 2001-09-06 Erhöhte in vitro-synthese von aktiven, disulfidbrücken-enthaltenden proteinen ATE448322T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US23038100P 2000-09-06 2000-09-06
PCT/US2001/028159 WO2002020818A1 (en) 2000-09-06 2001-09-06 Enhanced in vitro synthesis of active proteins containing disulfide bonds

Publications (1)

Publication Number Publication Date
ATE448322T1 true ATE448322T1 (de) 2009-11-15

Family

ID=22865001

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01968701T ATE448322T1 (de) 2000-09-06 2001-09-06 Erhöhte in vitro-synthese von aktiven, disulfidbrücken-enthaltenden proteinen

Country Status (11)

Country Link
US (1) US6548276B2 (de)
EP (1) EP1315826B1 (de)
JP (1) JP4889185B2 (de)
AT (1) ATE448322T1 (de)
AU (2) AU8893101A (de)
CA (1) CA2419996C (de)
DE (1) DE60140458D1 (de)
DK (1) DK1315826T3 (de)
ES (1) ES2334887T3 (de)
PT (1) PT1315826E (de)
WO (1) WO2002020818A1 (de)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7041479B2 (en) * 2000-09-06 2006-05-09 The Board Of Trustess Of The Leland Stanford Junior University Enhanced in vitro synthesis of active proteins containing disulfide bonds
US20050176157A1 (en) * 2001-12-19 2005-08-11 Elena Vasilyeva Methods for detecting half-antibodies using chip-based gel electrophoresis
CA2477440A1 (en) * 2002-02-28 2003-09-04 Yaeta Endo Reaction solution for cell-free protein synthesis, method of preparing the same and protein synthesis method using the same
PT1539948E (pt) 2002-08-19 2010-01-20 Univ Leland Stanford Junior Métodos melhorados para a síntese de proteínas in vitro
KR100505744B1 (ko) * 2003-02-15 2005-08-03 드림바이오젠 주식회사 단백질의 수용성 형태로의 생산을 위한 무세포단백질생산방법
CN101014716B (zh) 2003-11-20 2015-06-10 小利兰·斯坦福大学托管委员会 体外蛋白质合成的改进方法
WO2005052567A1 (en) * 2003-11-24 2005-06-09 Biogen Idec Ma Inc. Methods for detecting half-antibodies using chip-based gel electrophoresis
WO2005105994A1 (ja) * 2004-04-30 2005-11-10 Post Genome Institute Co., Ltd. ジスルフィド架橋形成型インビトロタンパク質合成方法
DE102004032460B3 (de) * 2004-06-30 2005-08-18 Rina-Netzwerk Rna Technologien Gmbh Verfahren zur präparativen in vitro Proteinbiosynthese
US20070117179A1 (en) * 2005-09-27 2007-05-24 Invitrogen Corporation In vitro protein synthesis systems for membrane proteins that include adolipoproteins and phospholipid-adolipoprotein particles
CA2673765A1 (en) * 2007-01-18 2008-07-24 The Board Of Trustees Of The Leland Stanford Junior University Enhanced cell-free synthesis of active proteins containing disulfide bonds
WO2008106660A2 (en) * 2007-03-01 2008-09-04 Invitrogen Corporation Isolated phospholipid-protein particles
EP2586788B1 (de) 2007-07-09 2017-11-29 Genentech, Inc. Verhindern der Disulfid-Bindungsreduktion während der rekombinanten Herstellung von Polypeptiden
WO2010077806A1 (en) 2008-12-15 2010-07-08 Greenlight Biosciences, Inc. Methods for control of flux in metabolic pathways
CN102333878B (zh) * 2008-12-22 2015-08-26 绿光生物科学公司 用于制造化合物的组合物和方法
CN102051406A (zh) * 2009-11-03 2011-05-11 凯熙医药(武汉)有限公司 一种用于预报人体发生异常增殖或肿瘤发生风险的检测方法
KR20130071433A (ko) 2010-05-07 2013-06-28 그린라이트 바이오사이언시스, 아이엔씨. 효소의 재배치를 통한 대사 경로에서의 흐름의 제어 방법
US8916358B2 (en) 2010-08-31 2014-12-23 Greenlight Biosciences, Inc. Methods for control of flux in metabolic pathways through protease manipulation
CN104093848A (zh) 2011-09-09 2014-10-08 绿光生物科学公司 碳青霉烯(carbapenem)的无细胞制备
AU2013364025A1 (en) 2012-12-21 2015-07-23 Greenlight Biosciences, Inc. Cell-free system for converting methane into fuel, pyruvate or isobutanol
JP2016507520A (ja) 2013-01-23 2016-03-10 ザ ボード オブ トラスティーズ オブ ザ レランド スタンフォード ジュニア ユニバーシティー 安定化されたb型肝炎コアポリペプチド
WO2015021058A2 (en) 2013-08-05 2015-02-12 Greenlight Biosciences, Inc. Engineered proteins with a protease cleavage site
RU2017137788A (ru) 2015-03-30 2019-04-30 Гринлайт Байосайенсис, Инк. Бесклеточное получение рибонуклеиновой кислоты
SG11201808721YA (en) 2016-04-06 2018-11-29 Greenlight Biosciences Inc Cell-free production of ribonucleic acid
AU2017262734B2 (en) * 2016-05-10 2020-04-30 Medimmune, Llc Prevention of protein disulfide bond reduction
US11951165B2 (en) 2016-12-30 2024-04-09 Vaxcyte, Inc. Conjugated vaccine carrier proteins
IL267709B2 (en) 2016-12-30 2025-04-01 Vaxcyte Inc Polypeptide-antigen conjugates with unnatural amino acids
KR20190100386A (ko) 2017-01-06 2019-08-28 그린라이트 바이오사이언시스, 아이엔씨. 당의 무세포 생산
US11898187B2 (en) 2017-08-15 2024-02-13 Northwestern University Protein glycosylation sites by rapid expression and characterization of N-glycosyltransferases
WO2019075167A1 (en) 2017-10-11 2019-04-18 Greenlight Biosciences, Inc. METHODS AND COMPOSITIONS FOR THE PRODUCTION OF NUCLEOSIDE TRIPHOSPHATE AND RIBONUCLEIC ACID
US11673921B2 (en) 2017-11-10 2023-06-13 Northwestern University Cell-free protein synthesis platform derived from cellular extracts of Vibrio natriegens
WO2019204346A1 (en) 2018-04-16 2019-10-24 Northwestern University METHODS FOR CO-ACTIVATING IN VITRO NON-STANDARD AMINO ACID (nsAA) INCORPORATION AND GLYCOSYLATION IN CRUDE CELLLYSATES
US11814621B2 (en) 2018-06-01 2023-11-14 Northwestern University Expanding the chemical substrates for genetic code reprogramming
WO2020010356A1 (en) 2018-07-06 2020-01-09 Northwestern University Ribosome variants for sequence defined polymer synthesis
WO2020072127A2 (en) 2018-08-03 2020-04-09 Northwestern University On demand, portable, cell-free molecular sensing platform
WO2020212477A1 (en) 2019-04-16 2020-10-22 Bachem Holding Ag Manufacture of disulfide bonded peptides
JP7837503B2 (ja) * 2020-10-02 2026-03-31 株式会社セルフリーサイエンス 分子内又は分子間にジスルフィド結合を有するタンパク質の合成方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2660397A (en) * 1996-04-05 1997-10-29 Board Of Regents, The University Of Texas System Methods for producing soluble, biologically-active disulfide bond-containing eukaryotic proteins in bacterial cells

Also Published As

Publication number Publication date
PT1315826E (pt) 2010-02-19
US6548276B2 (en) 2003-04-15
CA2419996C (en) 2012-11-06
DE60140458D1 (de) 2009-12-24
EP1315826B1 (de) 2009-11-11
EP1315826A4 (de) 2004-08-04
AU2001288931B2 (en) 2006-08-10
ES2334887T3 (es) 2010-03-17
CA2419996A1 (en) 2002-03-14
AU8893101A (en) 2002-03-22
US20020058303A1 (en) 2002-05-16
JP4889185B2 (ja) 2012-03-07
WO2002020818A1 (en) 2002-03-14
EP1315826A1 (de) 2003-06-04
JP2004508050A (ja) 2004-03-18
DK1315826T3 (da) 2010-03-22

Similar Documents

Publication Publication Date Title
DE60140458D1 (de) Erhöhte in vitro-synthese von aktiven, disulfidbrücken-enthaltenden proteinen
ATE342962T1 (de) Zusammensetzungen und verfahren für verbesserte zellkultur
ATE500323T1 (de) Subtilisin-variante
DE60322339D1 (de) Bindungsproteine als biosensoren
MY163480A (en) Sclerostin binding agents
NO2017028I1 (no) eftrenonacog alfa eller et biotilsvarende legemiddel ihht Artikkel 10(4) av Directive 2001/83/EC, som beskyttet av basispatentet.
ATE405650T1 (de) Produktion von ganzen antikörpern in prokaryontischen zellen
BR0315275A (pt) Anticorpos que se ligam a receptor de eritropoietina
NO20043245L (no) Bindingsproteiner som biosensorer
MY148759A (en) Methods to culture circovirus
WO2003020756A3 (en) Hybrid and tandem expression of neisserial proteins
DE60133426D1 (de) Verbesserter zerfall und rückfaltung von proteinen mittels hohen drucks
DE69939327D1 (de) Funktionelle antagonisten von hedgehog-aktivität
WO2002006457A3 (en) Novel lipase genes
DE60042209D1 (de) Enzymatische synthese von deoxyribonucleotiden
WO2003065003A3 (en) Nuclear matrix protein alterations associated with colon cancer and colon metastasis to the liver, and uses thereof
ATE464320T1 (de) Ntb-a, ein oberflächenmolekül impliziert in der aktivität natürlicher killerzellen (nk)
WO2002072057A3 (en) Topical composition comprising a functionally acylating cosmetic bonding agent
DE69734596D1 (de) "smoothened" proteine aus wirbeltieren
ATE452650T1 (de) Transferrin-fusionsproteinbibliotheken
WO2002062964A3 (en) Ap1 amine oxidase variants
WO2002068668A3 (en) Compositions and methods for production cell culture
DE60113535D1 (de) Kompositionen und verwendungen von cgi-69
WO2005003289A8 (en) Ap1 amine oxidase variants
WO2003046125A3 (en) Hin-2 nucleic acid molecules, proteins, antibodies, homologues, receptors, and uses thereof

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1315826

Country of ref document: EP